至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Structure-based design of broadly protective group a streptococcal M protein-based vaccines.

Vaccine. 2017-01; 
DaleJames B, SmeestersPierre R, CourtneyHarry S, PenfoundThomas A, HohnClaudia M, SmithJeremy C, BaudryJero
Products/Services Used Details Operation
Peptide Synthesis … A recombinant pentavalent E4 hybrid protein vaccine containing the same M peptides was produced from extracts of E. coli containing pUC57 into which was inserted a chemically synthesized hybrid gene (Genscript, Piscataway, NJ), using methods previously described [7 … Get A Quote

摘要

A major obstacle to the development of broadly protective M protein-based group A streptococcal (GAS) vaccines is the variability within the N-terminal epitopes that evoke potent bactericidal antibodies. The concept of M type-specific protective immune responses has recently been challenged based on the observation that multivalent M protein vaccines elicited cross-reactive bactericidal antibodies against a number of non-vaccine M types of GAS. Additionally, a new "cluster-based" typing system of 175M proteins identified a limited number of clusters containing closely related M proteins. In the current study, we used the emm cluster typing system, in combination with computational structure-based peptide ... More

关键词

Broadly neutralizing antibodies,Group A streptococcal vaccine,M protein,Structure-based de